On May 9, 2019 the Food and Drug Administration issued a “Recommendations for Reducing the Risk of Transfusion-Transmitted Babesiosis” guidance document with a maximum 12 month implementation timeline. Per the FDA guidance document recommendations, CTS is developing a specific implementation plan for mandatory Babesia testing well before the May 8, 2020 deadline.
Check out the Communication page for the complete details by clicking the link: Communications
We have now added a new section called the "Assay History List" to the "At A Gla...
Just a reminder that the revised client forms implement today! Don't forget to toss your o...
CTS will implement the Bio-Rad Geenius HIV 1/2 supplemental assay on Monday September 21, 2020. The ...
Creative Testing Solutions, the largest nonprofit blood testing organization in the U.S., today anno...
On September 14, 2020, our Phoenix laboratory began performing a portion of our alternate donor anti...
The recent communication regarding the recent Anti-SARS-CoV-2 Total assay in Tampa has brought about...